EGFR and neoplasm: Identifying drug-gable kinases upstream of the GABP-TERT axis such as EGFR and AMPK could facilitate future targeting of telomere maintenance, although this would require testing combinations with additional approaches to reduce TERT to a critically low level that is insufficient to maintain telomeres as tumor cells proliferate (Agarwal et al., 2021).